摘要:
The present application provides idebenone derivatives or analogues useful for treating a disease or disorder in a subject in need thereof. Pharmaceutical compositions comprising the compounds and methods of treating the disease or disorder are also provided.
摘要:
The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl substituted C 1 -C 8 alkyl, aryl-C 0-4 -alkyl, substituted aryl-C 0-4 -alkyl, heteroaryl-C 0-4 -alkyl, substituted heteroaryl-C 0-4 -alkyl, C 3 -C 6 cycloalkylaryl-C 0-2 -alkyl, and substituted C 3 -C 6 cycloalkylaryl-C 0-2 -alkyl;(b) X is an optionally substituted C 1 -C 5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S; (c) Y is C, O, S, NH or a single bond; and (d) E is selected from the group consisting of hydrogen, C(R3)(R4)A, A, (CH 2 )n COOR19 and substituted (CH 2 ) n COOR19.
摘要:
Novel N -alkyl- or alkenylcarbamoyl-N -acylamino acid esters represented by general formula (1); (wherein R is linear or branched C7-C21 alkyl or alkenyl; R is linear, branched or cyclic C1-C22 alkyl or alkenyl; R is linear, branched or cyclic C8-C22 alkyl or alkenyl; and n is an integer of 2 to 4). These esters can gel or coagulate a wide variety of liquid organic media by the addition thereof even in a small amount to give gels excellent in long-term and ordinary-temperature stability, and can be synthesized by an easy and simple process, thus being useful as excellent gelling or coagulating agents.
摘要:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要:
This invention relates to new propanolamine derivatives or salts thereof represented by general formula (I), wherein each symbol is as defined in the specification or salts thereof which are beta 3 adrergenic receptor agonists and therefore have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment of diseases indicated in the specification to a human being or an animal.
摘要:
Compounds of formula (II): wherein A, R 1 , R 2 , R 5 and R 13 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds have activity as SHIP1 modulators, and thus may be useful in treating a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of the invention are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
摘要:
Acylfulvene analogs, which inhibit tumor growth, especially solid tumor growth, and which have an adequate therapeutic index to be effective for in vivo treatment are provided herein. The compounds described herein are useful as anti-neoplastic agents, i.e., to inhibit tumor cell growth in vitro or in vivo,
摘要:
The invention relates to tetracyclo[6.6.2.0 .0 ]hexadeca-2(7),3,5,9(14),10,12-hexaene derivatives of general formula (I), wherein R1 and R2 are hydrogen or a halogen atom and are the same or different, X is hydrogen and Y is a group -NR3R4 or a group -N CH3R3R4 or X and Y together form a group CH2-NR5, and Z represents a -CH2-group or a C=NH-group.
摘要翻译:本发明涉及四环[6.6.2.0 <2,7> 0.0 <9.14>] hexadeca-2(7),-3,5,9-(14),通式-10,12- hexaenderivate(I),其中R1 和R 2相同或不同,是氢或卤原子,X是氢和Y是基团-NR 3 R 4或基团-N意味着<+> CH3R3R4或X和Y一起形成基团-CH 2 NR 5和Z表示-CH 2基团或 C = NH组。
摘要:
Compuestos químicos obtenidos por modelación molecular in silico, y cuya estructura permite el bloqueo de la fosforilación mediante la interacción de dichos compuestos con el dominio de fosforilación o su entorno en los sustratos de la enzima Caseína Kinasa 2. La invención comprende además las composiciones farmacéuticas que contienen dichos compuestos y su uso en la preparación de medicamentos para el tratamiento de enfermedades relacionadas con procesos neoplásicos.
摘要:
The present invention is directed to novel phenytoin derivative compounds and the use of such compounds as sodium channel blockers. Such compositions have utility as anti-cancer agents and can be used to limit or prevent PCa growth and/or metastasis.